ANANDA Scientific and NYU Grossman School of Medicine Announce Second Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for Evaluating Its Effect on Opioid Sparing in Participants with Chronic Radiculopathic Pain Syndromes

https://www.businesswire.com/news/home/20210128005188/en